Literature DB >> 17621246

A comparison of cervical and vaginal human papillomavirus.

Philip E Castle1, Ana C Rodriguez, Carolina Porras, Rolando Herrero, Mark Schiffman, Paula Gonzalez, Allan Hildesheim, Robert D Burk.   

Abstract

OBJECTIVES: We wanted to compare detection of a broad spectrum of human papillomavirus (HPV) types detected in cellular specimens from the vagina and cervix, which could provide information about the potential of each anatomical site for harboring infection. Previous studies have failed to present data on or detect a broad spectrum of HPV genotypes and/or have not carefully sampled the vagina, instead relying on self-collection that is likely contaminated with cervical cells. STUDY
DESIGN: We conducted follow-up study of 353 women who had participated in study of HPV and cervical neoplasia in Costa Rica. We collected paired cervical and vaginal specimens; vaginal specimens were collected from the fornix to minimize cervical contamination. Specimens were tested in a masked fashion for >40 HPV types using a MY09/MY11 PCR method and type-specific dot blot hybridization.
RESULTS: The prevalence for any carcinogenic HPV type in vaginal and cervical specimens was similar (P = 0.3). However, the prevalence for any HPV type in vaginal specimens was greater than in cervical specimens (P = 0.0002), primarily due to a twofold increased vaginal prevalence of HPV types of the alpha3/alpha15 phylogenetic species (e.g., HPV61) (P <0.00005).
CONCLUSIONS: Carcinogenic HPV types appeared to have a similar affinity for vaginal and cervical epithelium, but noncarcinogenic HPV types of the alpha3/alpha15 phylogenetic species may have a tropism for vaginal epithelium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621246      PMCID: PMC3962831          DOI: 10.1097/OLQ.0b013e318064c8c5

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  17 in total

Review 1.  Chapter 2: The burden of HPV-related cancers.

Authors:  D Maxwell Parkin; Freddie Bray
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

2.  Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.

Authors:  Aimée R Kreimer; Hormuzd A Katki; Mark Schiffman; Cosette M Wheeler; Philip E Castle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-01       Impact factor: 4.254

3.  Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

Authors:  Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana C Rodriguez; Martha L Hutchinson; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

4.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Authors:  Xavier Castellsagué; Mireia Díaz; Silvia de Sanjosé; Nubia Muñoz; Rolando Herrero; Silvia Franceschi; Rosanna W Peeling; Rhoda Ashley; Jennifer S Smith; Peter J F Snijders; Chris J L M Meijer; F Xavier Bosch
Journal:  J Natl Cancer Inst       Date:  2006-03-01       Impact factor: 13.506

5.  Agreement between self- and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa.

Authors:  Heidi E Jones; Bruce R Allan; Janneke H H M van de Wijgert; Lydia Altini; Sylvia M Taylor; Alana de Kock; Nicol Coetzee; Anna-Lise Williamson
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

6.  Age-related changes of the cervix influence human papillomavirus type distribution.

Authors:  Philip E Castle; Jose Jeronimo; Mark Schiffman; Rolando Herrero; Ana C Rodríguez; M Concepción Bratti; Allan Hildesheim; Sholom Wacholder; L Rodney Long; Leif Neve; Ruth Pfeiffer; Robert D Burk
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.

Authors:  P E Gravitt; J V Lacey; L A Brinton; W A Barnes; J R Kornegay; M D Greenberg; S M Greene; O C Hadjimichael; L McGowan; R Mortel; P E Schwartz; R Zaino; A Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-02       Impact factor: 4.254

8.  Human papillomavirus prevalence in women who have and have not undergone hysterectomies.

Authors:  Philip E Castle; Mark Schiffman; Andrew G Glass; Brenda B Rush; David R Scott; Sholom Wacholder; Anne Dunn; Robert D Burk
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

9.  The carcinogenicity of human papillomavirus types reflects viral evolution.

Authors:  Mark Schiffman; Rolando Herrero; Rob Desalle; Allan Hildesheim; Sholom Wacholder; Ana Cecilia Rodriguez; Maria C Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Thomas C Wright; Diane Solomon; Zigui Chen; John Schussler; Philip E Castle; Robert D Burk
Journal:  Virology       Date:  2005-06-20       Impact factor: 3.616

10.  Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.

Authors:  Rolando Herrero; Philip E Castle; Mark Schiffman; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Sabrina Chen; Ana C Rodriguez; Robert D Burk
Journal:  J Infect Dis       Date:  2005-05-02       Impact factor: 5.226

View more
  35 in total

1.  Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-20       Impact factor: 4.254

2.  A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.

Authors:  Cosette M Wheeler; William C Hunt; Jack Cuzick; Erika Langsfeld; Amanda Pearse; George D Montoya; Michael Robertson; Catherine A Shearman; Philip E Castle
Journal:  Int J Cancer       Date:  2012-06-20       Impact factor: 7.396

3.  Response to Pretorius and Belinson.

Authors:  Mark Schiffman; Liming Hu; Sameer Antani; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2020-01-01       Impact factor: 13.506

4.  A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.

Authors:  Mark Schiffman; Andrew G Glass; Nicolas Wentzensen; Brenda B Rush; Philip E Castle; David R Scott; Julie Buckland; Mark E Sherman; Greg Rydzak; Peter Kirk; Attila T Lorincz; Sholom Wacholder; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-20       Impact factor: 4.254

5.  A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents.

Authors:  David H Adler; Fatima Laher; Erica Lazarus; Katherine Grzesik; Glenda E Gray; Bruce Allan; Anna-Lise Williamson
Journal:  J Immunol Tech Infect Dis       Date:  2013-09-18

6.  Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.

Authors:  Anneli Uusküla; Mart Kals; Liina Kosenkranius; Louise-Anne McNutt; Jack DeHovitz J
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

7.  The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women.

Authors:  Anne F Rositch; Michelle I Silver; Anne Burke; Raphael Viscidi; Kathryn Chang; Cindy M P Duke; Wen Shen; Patti E Gravitt
Journal:  J Low Genit Tract Dis       Date:  2013-01       Impact factor: 1.925

8.  High prevalence of human papillomaviruses in Ghanaian pregnant women.

Authors:  Marco H Schulze; Fabian M Völker; Raimond Lugert; Paul Cooper; Kai Hasenclever; Uwe Groß; Herbert Pfister; Steffi Silling
Journal:  Med Microbiol Immunol       Date:  2016-09-06       Impact factor: 3.402

9.  Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic.

Authors:  Vikrant V Sahasrabuddhe; Patti E Gravitt; S Terence Dunn; David Brown; Richard A Allen; Yolanda J Eby; Katie Smith; Rosemary E Zuna; Roy R Zhang; Michael A Gold; Mark Schiffman; Joan L Walker; Philip E Castle; Nicolas Wentzensen
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

10.  Correlates of cervicovaginal human papillomavirus detection in perimenopausal women.

Authors:  Keri N Althoff; Proma Paul; Anne E Burke; Raphael Viscidi; Meera Sangaramoorthy; Patti E Gravitt
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.